rs9298506 — SOX17

Regulatory tag variant near SOX17 at chromosome 8q11.23 associated with intracranial aneurysm susceptibility in European and East Asian populations; A allele confers elevated risk through putative effects on SOX17 endothelial transcription factor expression

See your personal result for SOX17

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

SOX17 and Intracranial Aneurysm — An Endothelial Blueprint Variant

SOX17 is not a structural gene — it is a master regulator. SOX1711 SOX17
SRY-related HMG-box 17: a transcription factor essential for specification and maintenance of endothelial cell identity during embryonic and adult vascular development encodes a transcription factor that directly controls the genetic programs that make endothelial cells — the cells lining every blood vessel in the body — what they are. When SOX17 expression is altered, the endothelial monolayer loses integrity, vessel walls weaken, and the hemodynamic stresses of arterial blood flow become harder to contain. rs9298506 is a regulatory tag variant located approximately 64 kilobases downstream of the SOX17 coding sequence at chromosome 8q11.23. It does not change the SOX17 protein directly, but by sitting in regulatory sequence it can influence how much SOX17 is produced — with consequences for vascular wall maintenance throughout life.

The Mechanism

SOX17 regulates endothelial cell fate from embryogenesis through adulthood. It targets genes that govern endothelial junction integrity, vascular smooth muscle cell communication, and extracellular matrix remodeling. Arterial branch points — particularly those in the cerebral circulation where intracranial aneurysms preferentially form — experience the highest hemodynamic shear stress in the body. SOX17 expression maintains the shear-stress response program22 SOX17 expression maintains the shear-stress response program
Loss-of-function experiments show that SOX17-depleted endothelial cells fail to upregulate junction proteins and are more prone to inflammatory activation under flow conditions. When this transcriptional program is subtly impaired by a regulatory variant, the cumulative effect over decades may be a vessel wall that is marginally less resistant to aneurysm formation.

The GWAS Catalog annotates rs9298506 near the RP1 gene (8q12.1), but the 2008 Bilguvar discovery team explicitly noted that associated SNPs on 8q "likely act via SOX17, which is required for formation and maintenance of endothelial cells, suggesting a role in development and repair of the vasculature." The variant's position and the biological plausibility of SOX17 as the effector gene make this the most mechanistically coherent explanation. Heritability enrichment analysis33 Heritability enrichment analysis
identifying which cell types' open chromatin regions explain the most GWAS signal from the 2020 Bakker et al. GWAS independently confirmed that intracranial aneurysm heritability is concentrated in endothelial cell epigenetic marks — exactly the cell type SOX17 controls.

The Evidence

The original discovery came from the landmark Bilguvar et al. 200844 Bilguvar et al. 2008
Susceptibility loci for intracranial aneurysm in European and Japanese populations, Nature Genetics genome-wide association study. Spanning Finnish, Dutch, and Japanese cohorts totalling more than 2,100 intracranial aneurysm cases and 8,000 controls, the study identified the chromosome 8q locus — with rs9298506-A as the risk allele — among three genome-wide significant hits (OR approximately 1.35 in the 8q range).

The 8q SOX17 association was confirmed in a larger Yasuno et al. 201055 Yasuno et al. 2010
Genome-wide association study of intracranial aneurysm identifies three new risk loci, Nature Genetics multi-cohort GWAS: 5,891 cases and 14,181 controls from European and Japanese populations. rs9298506-A reached p=1×10⁻¹² with OR 1.28 (95% CI 1.20–1.38) — each copy of the A allele raises intracranial aneurysm odds by approximately 28% relative to the protective G allele.

A Korean case-control and East-Asian meta-analysis66 Korean case-control and East-Asian meta-analysis
Hong et al. 2018 World Neurosurgery pooling 5,100 IA cases and 7,930 controls confirmed the rs9298506 association in Asian populations: OR 1.19 (95% CI 1.07–1.32, p=0.0016) for the A allele risk direction, consistent across ancestry groups. The Bakker et al. 202077 Bakker et al. 2020
Nature Genetics cross-ancestry GWAS of 10,754 cases and 306,882 controls further validated that loci in this region contribute to intracranial aneurysm risk within a polygenic architecture, with heritability concentrated in endothelial cell biology.

A Deka et al. 201088 Deka et al. 2010
Stroke study of 406 familial IA cases found that the 8q11 SOX17 signal (rs10958409, in strong LD with rs9298506) interacted multiplicatively with smoking — a gene-environment interaction meaning the risk conferred by this locus is significantly amplified in smokers. This is one of the strongest gene-environment interactions documented for intracranial aneurysm risk.

The evidence is classified as strong: consistent replication across European and East Asian GWAS in independent cohorts, a clear biological candidate gene with an established vascular role, and documented gene-environment interaction with smoking.

Practical Actions

The A allele at rs9298506 is the most common allele globally (~81%), meaning the majority of people carry at least one copy. However, the per-allele OR of ~1.28 is real and clinically meaningful — it is comparable in magnitude to other established cardiovascular risk variants. For AA homozygotes, the cumulative effect of two risk alleles is particularly relevant when combined with other risk factors.

The two most important actionable modifiers of SOX17-locus aneurysm risk are: smoking cessation (the gene-environment interaction documented by Deka et al. means smoking specifically amplifies 8q11 locus risk) and blood pressure control (the primary hemodynamic driver of aneurysm formation and rupture regardless of genetic background). For individuals with a family history of intracranial aneurysm or subarachnoid hemorrhage, this genetic finding adds weight to the case for discussing proactive MRI angiography screening with a physician.

Interactions

rs9298506 is the second SOX17-region variant in this intracranial aneurysm panel; the other SOX17-region GWAS tag SNP rs10958409 (analyzed in the Deka 2010 Stroke study) is in linkage disequilibrium with rs9298506 and tags the same 8q11.23 susceptibility locus. These two SNPs should not be treated as additive independent risk signals — they reflect the same underlying association.

The SOX17 locus acts additively with other independently replicated intracranial aneurysm susceptibility loci, including rs1333040 at 9p21 (near CDKN2A/B, the most robustly replicated IA locus), rs700651 at 2q33.1 (BOLL), and rs767603 at 14q23. These loci operate through distinct pathway nodes — endothelial identity (SOX17), cell cycle senescence (9p21), RNA splicing regulation (2q33.1), and vascular wall regulatory elements (14q23) — and their risk contributions are additive in polygenic models. Individuals carrying risk alleles across multiple loci have substantially higher absolute risk than any single locus implies.

Genotype Interpretations

What each possible genotype means for this variant.

GG Normal

Protective genotype — reduced genetic susceptibility to intracranial aneurysm at the SOX17 locus

You carry two copies of the G allele at rs9298506, the rare protective genotype found in approximately 3.5% of the global population. The G allele is the non-risk allele at this SOX17-region locus — GG homozygotes have the lowest genetic susceptibility to intracranial aneurysm among the three possible genotypes. Because the G allele is uncommon globally (~19%), this protective configuration is found in a small minority of people. Your risk at this particular locus is below the population average. Standard cardiovascular risk factor management applies.

AG Intermediate

One copy of the risk A allele — modestly elevated genetic susceptibility at the SOX17 locus

The A allele at rs9298506 was first identified in the landmark Bilguvar et al. 2008 Nature Genetics GWAS (>2,100 cases, 8,000 controls across Finnish, Dutch, and Japanese cohorts) and confirmed by Yasuno et al. 2010 in 5,891 cases and 14,181 controls, with the rs9298506-A risk allele reaching p=1×10⁻¹² (OR 1.28, 95% CI 1.20–1.38). An East-Asian meta-analysis (Hong et al. 2018, 5,100 cases and 7,930 controls) confirmed the association in Asian populations (OR 1.19, 95% CI 1.07–1.32).

The 8q11.23 locus likely acts through SOX17, a transcription factor essential for endothelial cell identity and vascular wall maintenance. As an AG heterozygote, you carry one copy of the regulatory variant that subtly shifts SOX17 expression levels in endothelial cells, contributing to marginally reduced vascular wall integrity at high-stress arterial branch points over a lifetime.

A critical gene-environment interaction was documented by Deka et al. 2010 (Stroke): the 8q11 SOX17 locus signal interacted multiplicatively with smoking in a familial IA cohort, meaning tobacco exposure specifically amplifies the risk conferred by this locus. This interaction is the most actionable finding from the literature for carriers.

AA High Risk

Two copies of the A risk allele — highest genetic susceptibility at the SOX17 locus for intracranial aneurysm

The A allele at rs9298506 was replicated at genome-wide significance across multiple large GWAS: the 2008 Bilguvar Nature Genetics study identified the 8q locus (OR ~1.35), the 2010 Yasuno study confirmed rs9298506-A at OR 1.28 (95% CI 1.20–1.38, p=1×10⁻¹²) in 5,891 cases across European and Japanese populations, and the 2018 Hong et al. East-Asian meta-analysis further confirmed the association (OR 1.19, 95% CI 1.07–1.32) in 5,100 Asian IA cases.

Because the A allele is common (~81% globally), most people are AA homozygotes — this is the population baseline, not an outlier. However, individuals with AA who also carry risk genotypes at other IA loci (rs1333040 at 9p21, rs700651 at 2q33.1) accumulate substantially higher polygenic risk than any single locus implies. The 2020 Bakker Nature Genetics GWAS demonstrated that intracranial aneurysm has a polygenic architecture, and cumulative genetic risk across independently confirmed loci drives clinically relevant risk stratification.

The documented multiplicative interaction between this locus and smoking (Deka et al. 2010, Stroke) means AA carriers who smoke have disproportionately elevated aneurysm susceptibility — greater than the sum of genetic risk and smoking risk alone.

SOX17 encodes a transcription factor essential for endothelial cell identity at arterial branch points — exactly where intracranial aneurysms preferentially form in the circle of Willis. Two copies of the regulatory risk allele at this locus represent a chronic, lifelong reduction in the genetic program that maintains vascular wall integrity under hemodynamic stress.